Adjuvant immune checkpoint inhibitor therapy may benefit pediatric patients with stage III melanoma and sentinel lymph node positivity: a case series.
Saved in:
| Title: | Adjuvant immune checkpoint inhibitor therapy may benefit pediatric patients with stage III melanoma and sentinel lymph node positivity: a case series. |
|---|---|
| Authors: | Bowden A; School of Medicine and Dentistry, University of Rochester, Rochester, New York, USA., Zambito J; Department of Dermatology, University of Rochester Medical Center, Rochester, New York, USA., El-Feghaly J; Department of Dermatology, University of Rochester Medical Center, Rochester, New York, USA.; Department of Pediatrics, Golisano Children's Hospital, Rochester, New York, USA., Andolina JR; Department of Pediatrics, Golisano Children's Hospital, Rochester, New York, USA. |
| Source: | Pediatric hematology and oncology [Pediatr Hematol Oncol] 2024 Sep; Vol. 41 (6), pp. 389-398. Date of Electronic Publication: 2024 May 07. |
| Publication Type: | Journal Article; Case Reports |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 8700164 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0669 (Electronic) Linking ISSN: 08880018 NLM ISO Abbreviation: Pediatr Hematol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
